• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by RH

    9/26/24 5:22:04 PM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary
    Get the next $RH alert in real time by email
    SC 13G 1 tm2425031d1_sc13g.htm SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G*

    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO § 240.13d-2

    (Amendment No. __)*

     

    RH
    (Name of Issuer)
     
    Common Stock, par value $0.0001 per share (the “Shares”)
    (Title of Class of Securities)
     
    74967X103
    (CUSIP Number)
     
    September 16, 2024
    (Date of Event Which Requires Filing of the Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. 74967X103 13G Page 2 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel Securities LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    497,521 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    2.7%1

    12.

    TYPE OF REPORTING PERSON

     

    BD; OO

     

     

    1 The percentages reported in this Schedule 13G are based upon 18,482,697 Shares outstanding as of September 6, 2024 (according to the issuer’s Form 10-Q as filed with the Securities and Exchange Commission on September 12, 2024). Except as described in the preceding sentence, all Shares for the holdings of the reporting persons reported in this Schedule 13G are as of the opening of the market on September 26, 2024

     

     

     

     

    CUSIP No. 74967X103 13G Page 3 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel Securities Group LP

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    702,655 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.8%

    12.

    TYPE OF REPORTING PERSON

     

    PN; HC

           

     

     

     

    CUSIP No. 74967X103 13G Page 4 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel Securities GP LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    702,655 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.8%

    12.

    TYPE OF REPORTING PERSON

     

    OO; HC

           

     

     

     

     

    CUSIP No. 74967X103 13G Page 5 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel Advisors LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    14,489 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.1%

    12.

    TYPE OF REPORTING PERSON

     

    IA; OO; HC

           

     

     

     

    CUSIP No. 74967X103 13G Page 6 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel Advisors Holdings LP

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    14,489 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.1%

    12.

    TYPE OF REPORTING PERSON

     

    PN; HC

           

     

     

     

    CUSIP No. 74967X103 13G Page 7 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Citadel GP LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    14,489 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.1%

    12.

    TYPE OF REPORTING PERSON

     

    OO; HC

           

     

     

     

    CUSIP No. 74967X103 13G Page 8 of 13 Pages

     

    1.

    NAME OF REPORTING PERSONS

     

    Kenneth Griffin

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a)     ¨

    (b)     ¨

     

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    U.S. Citizen

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5.

    SOLE VOTING POWER

     

    0

    6.

    SHARED VOTING POWER

     

    717,144 Shares

    7.

    SOLE DISPOSITIVE POWER

     

    0

    8.

    SHARED DISPOSITIVE POWER

     

    See Row 6 above

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    See Row 6 above

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

     

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    3.9%

    12.

    TYPE OF REPORTING PERSON

     

    IN; HC

           

     

     

     

    CUSIP No. 74967X103 13G Page 9 of 13 Pages

     

    Item 1(a). Name of Issuer:
       
      RH
       
    Item 1(b). Address of Issuer’s Principal Executive Offices:
       
      15 Koch Road, Suite K, Corte Madera, CA 94925
       
    Item 2(a). Name of Person Filing:
       
      This Schedule 13G is being jointly filed by Citadel Securities LLC (“Citadel Securities”), Citadel Securities Group LP (“CALC4”), Citadel Securities GP LLC (“CSGP”), Citadel Advisors LLC (“Citadel Advisors”), Citadel Advisors Holdings LP (“CAH”), Citadel GP LLC (“CGP”), and Mr. Kenneth Griffin (collectively with Citadel Securities, CALC4, CSGP, Citadel Advisors, CAH, and CGP, the “Reporting Persons”) with respect to the Shares of the above-named issuer owned by Citadel Securities, CRBU Holdings LLC, a Delaware limited liability company (“CRBH”), Citadel Securities Principal Strategies LLC, a Delaware limited liability company (“CSP”), and Citadel Quantitative Strategies Master Fund Ltd., a Cayman Islands company (“QSMF”).  Such owned Shares may include other instruments exercisable for or convertible into Shares.
       
      CALC4 is the non-member manager of Citadel Securities, CRBH, and CSP.  CSGP is the general partner of CALC4.  Citadel Advisors is the portfolio manager for QSMF.  CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH.  Mr. Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP.
       
      The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).
       
    Item 2(b). Address or Principal Business Office or, if none, Residence:
       
      The address of each of the Reporting Persons is Southeast Financial Center, 200 S. Biscayne Blvd., Suite 3300, Miami, Florida 33131.
       
    Item 2(c). Citizenship:
       
      Each of Citadel Securities, CSGP, Citadel Advisors, and CGP is organized as a limited liability company under the laws of the State of Delaware.  Each of CALC4 and CAH is organized as a limited partnership under the laws of the State of Delaware.  Mr. Griffin is a U.S. citizen.
       
    Item 2(d). Title of Class of Securities:
       
      Common Stock, par value $0.0001 per share
       
    Item 2(e). CUSIP Number:
       
      74967X103

     

     

     

     

    CUSIP No. 74967X103 13G Page 10 of 13 Pages

     

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
       
      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
      (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
      (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
      (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
             
      If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________.             
             
    Item 4. Ownership:
             
      A. Citadel Securities LLC
             
        (a) Citadel Securities LLC may be deemed to beneficially own 497,521 Shares.
             
        (b) The number of Shares that Citadel Securities LLC may be deemed to beneficially own constitutes 2.7% of the Shares outstanding.
             
        (c) Number of Shares as to which such person has:
             
          (i) sole power to vote or to direct the vote:  0
             
          (ii) shared power to vote or to direct the vote:  497,521
             
          (iii) sole power to dispose or to direct the disposition of:  0
             
          (iv) shared power to dispose or to direct the disposition of:  497,521

     

     

     

     

    CUSIP No. 74967X103 13G Page 11 of 13 Pages

     

      B. Citadel Securities Group LP and Citadel Securities GP LLC
             
        (a) Each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own 702,655 Shares.
           
        (b) The number of Shares that each of Citadel Securities Group LP and Citadel Securities GP LLC may be deemed to beneficially own constitutes 3.8% of the Shares outstanding.
           
        (c) Number of Shares as to which such person has:
           
          (i) sole power to vote or to direct the vote:  0
             
          (ii) shared power to vote or to direct the vote:  702,655
             
          (iii) sole power to dispose or to direct the disposition of:  0
             
          (iv) shared power to dispose or to direct the disposition of:  702,655
             
      C. Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC
             
        (a) Each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own 14,489 Shares.
           
        (b) The number of Shares that each of Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC may be deemed to beneficially own constitutes 0.1% of the Shares outstanding.
           
        (c) Number of Shares as to which such person has:
           
          (i) sole power to vote or to direct the vote:  0
             
          (ii) shared power to vote or to direct the vote:  14,489
             
          (iii) sole power to dispose or to direct the disposition of:  0
             
          (iv) shared power to dispose or to direct the disposition of:  14,489
             

     

     

     

    CUSIP No. 74967X103 13G Page 12 of 13 Pages

     

      D. Kenneth Griffin
             
        (a) Mr. Griffin may be deemed to beneficially own 717,144 Shares.
           
        (b) The number of Shares that Mr. Griffin may be deemed to beneficially own constitutes 3.9% of the Shares outstanding.
           
        (c) Number of Shares as to which such person has:
           
          (i) sole power to vote or to direct the vote:  0
             
          (ii) shared power to vote or to direct the vote:  717,144
             
          (iii) sole power to dispose or to direct the disposition of:  0
             
          (iv) shared power to dispose or to direct the disposition of 717,144

     

    Item 5. Ownership of Five Percent or Less of a Class:
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following. o
       
    Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
       
      Not Applicable
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
       
      Not Applicable
       
    Item 8. Identification and Classification of Members of the Group:
       
      Not Applicable
       
    Item 9. Notice of Dissolution of Group:
       
      Not Applicable
       
    Item 10. Certifications:
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     

    CUSIP No. 74967X103 13G Page 13 of 13 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated September 26, 2024.

     

    CITADEL SECURITIES LLC   CITADEL ADVISORS LLC
             
    By: /s/ Guy Miller   By: /s/ Seth Levy
      Guy Miller, Authorized Signatory     Seth Levy, Authorized Signatory
             
    CITADEL SECURITIES GROUP LP   CITADEL ADVISORS HOLDINGS LP
             
    By: /s/ Guy Miller   By: /s/ Seth Levy
      Guy Miller, Authorized Signatory     Seth Levy, Authorized Signatory
             
    CITADEL SECURITIES GP LLC   CITADEL GP LLC
             
    By: /s/ Guy Miller   By: /s/ Seth Levy
      Guy Miller, Authorized Signatory     Seth Levy, Authorized Signatory
             
          KENNETH GRIFFIN
             
          By: /s/ Seth Levy
            Seth Levy, attorney-in-fact*

     

     

    *Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.

     

     

     

    Get the next $RH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RH

    DatePrice TargetRatingAnalyst
    4/3/2025$410.00 → $130.00Buy → Underperform
    BofA Securities
    4/3/2025$200.00Buy → Neutral
    Citigroup
    4/3/2025$420.00 → $280.00Outperform
    Telsey Advisory Group
    3/24/2025$500.00 → $420.00Outperform
    Telsey Advisory Group
    1/30/2025$261.00 → $374.00Sell → Neutral
    Goldman
    1/13/2025$435.00 → $530.00Equal-Weight → Overweight
    Morgan Stanley
    1/8/2025$383.00 → $515.00Equal Weight → Overweight
    Barclays
    12/19/2024$485.00 → $500.00Market Perform → Outperform
    Telsey Advisory Group
    More analyst ratings

    $RH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RH Provides Clarifications Related to the Reciprocal Tariffs Announced on April 2, 2025

      The Company Also Introduces Fiscal 2025 Free Cash Flow Outlook RH (NYSE:RH) provided the following clarifications today based on the market volatility related to the reciprocal tariffs announced on April 2, 2025. The Company has been operating with 25% tariffs from China since the last Trump administration and has successfully resourced the majority of its China production to Vietnam at significantly better than pre-tariff landed China pricing. In addition, the Company has successfully resourced a meaningful amount of its China production to its own factory in North Carolina. As discussed during the Company's fourth quarter earnings call on April 2, 2025, RH believes President Trump is u

      4/4/25 5:58:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH Reports Fourth Quarter and Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 8284432). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury

      4/2/25 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH to Report Fourth Quarter and Fiscal Year 2024 Financial Results on April 2, 2025

      RH (NYSE:RH) today announced that it will report financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, on Wednesday, April 2, 2025 after market close. RH's fourth quarter and fiscal year 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on April 2, 2025. The live conference call may be

      3/24/25 6:45:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    SEC Filings

    See more

    $RH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more

    $RH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • RH filed SEC Form 8-K: Leadership Update

      8-K - RH (0001528849) (Filer)

      4/28/25 4:15:23 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - RH (0001528849) (Filer)

      4/8/25 7:30:10 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 10-K filed by RH

      10-K - RH (0001528849) (Filer)

      4/2/25 4:59:08 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/18/21 5:24:40 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/18/21 5:24:40 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

      Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

      1/15/21 11:16:15 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/14/24 5:05:51 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/14/24 4:15:30 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by RH

      SC 13G/A - RH (0001528849) (Subject)

      11/12/24 10:34:15 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Financials

    Live finance-specific insights

    See more
    • RH Reports Fourth Quarter and Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 8284432). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury

      4/2/25 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH to Report Fourth Quarter and Fiscal Year 2024 Financial Results on April 2, 2025

      RH (NYSE:RH) today announced that it will report financial results for the fourth quarter and fiscal year 2024 ended February 1, 2025, on Wednesday, April 2, 2025 after market close. RH's fourth quarter and fiscal year 2024 financial results press release will include a shareholder letter from Chairman and Chief Executive Officer, Gary Friedman, highlighting the Company's continued evolution and recent performance. The shareholder letter and financial results will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) on April 2, 2025. The live conference call may be

      3/24/25 6:45:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH Reports Third Quarter Fiscal 2024 Results

      RH (NYSE:RH) has released its financial results for the third quarter ended November 2, 2024, in a shareholder letter from Chairman and Chief Executive Officer Gary Friedman, available on the Investor Relations section of its website at ir.rh.com. As previously announced, RH leadership will host a live conference call and audio webcast at 2:00 pm Pacific Time (5:00 pm Eastern Time) today. The live conference call may be accessed by dialing 800.715.9871 or 646.307.1963 for international callers (conference ID: 3000234). The call and replay can also be accessed via audio webcast at ir.rh.com. ABOUT RH RH (NYSE:RH) is a curator of design, taste and style in the luxury lifestyle market. T

      12/12/24 4:05:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Leadership Updates

    Live Leadership Updates

    See more
    • RH Announces the Appointment of Jarrett Stuhl as Chief Real Estate & Development Officer

      RH (NYSE:RH) today announced the appointment of Jarrett Stuhl as Chief Real Estate & Development Officer. Mr. Stuhl will lead Real Estate Development, Architecture & Design for all the Company's brands, concepts and facilities, domestically and internationally. Mr. Stuhl will report to RH's Chairman and Chief Executive Officer, Gary Friedman. Prior to joining RH, Mr. Stuhl spent nine years bringing Soho House & Co. Inc into new markets across the world. Ascending through the company, and lastly serving as Chief Operating Officer for The Americas, Mr. Stuhl had responsibility for real estate, development, membership, communications, food & beverage and hotel operations. Gary Friedman,

      1/18/24 8:32:00 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Remitly Appoints Two New Members to its Board of Directors

      SEATTLE, April 06, 2023 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a leading digital financial services provider for immigrants and their families, today announced the appointments of Phyllis Campbell and Ryno Blignaut to its Board of Directors.  "We are delighted to welcome Phyllis and Ryno to Remitly's Board of Directors," said Matt Oppenheimer, CEO of Remitly. "They each bring with them a wealth of knowledge and leadership experience to complement our existing team of accomplished directors. I'm grateful for their passion and dedication to our customer-centric vision for the future of digital financial services."  Campbell and Blignaut bring decades of leaders

      4/6/23 9:00:00 AM ET
      $RELY
      $RH
      Business Services
      Consumer Discretionary
      Other Specialty Stores

    $RH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by CHIEF ACCOUNTING OFFICER Hargarten Christina

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:09 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 4 filed by Officer Chaya Eri

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:07 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form 4 filed by Officer Duban Stefan

      4 - RH (0001528849) (Issuer)

      4/14/25 9:30:10 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CHAIRMAN & CEO Friedman Gary G bought $9,999,978 worth of shares (46,274 units at $216.10), increasing direct ownership by 1% to 3,351,337 units (SEC Form 4)

      4 - RH (0001528849) (Issuer)

      6/27/24 7:47:18 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary

    $RH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RH downgraded by BofA Securities with a new price target

      BofA Securities downgraded RH from Buy to Underperform and set a new price target of $130.00 from $410.00 previously

      4/3/25 12:54:00 PM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • RH downgraded by Citigroup with a new price target

      Citigroup downgraded RH from Buy to Neutral and set a new price target of $200.00

      4/3/25 8:16:49 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary
    • Telsey Advisory Group reiterated coverage on RH with a new price target

      Telsey Advisory Group reiterated coverage of RH with a rating of Outperform and set a new price target of $280.00 from $420.00 previously

      4/3/25 8:00:10 AM ET
      $RH
      Other Specialty Stores
      Consumer Discretionary